PTGX
NASDAQ · Biotechnology
Protagonist Therapeutics Inc
$146.15
+8.83 (+6.43%)
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Price Target
Analyst Price Target
-79.2% upside
Low Target
$24.78
Average Target
$30.47
High Target
$49.57
Current Price
$146.15
Current
$146.15
$146.15
Target
$30.47
$30.47
$24.78
$30.47 avg
$49.57
Scenario Analysis
Bear Case
$24.78
-83.0%
Low target
Base Case
$30.47
-79.2%
Avg target
Bull Case
$49.57
+-66.1%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$143.29
2.0% from high
52-Week Low
$50.49
+189.5% from low
50-Day SMA
$85.10
+71.7% vs SMA
200-Day SMA
$67.75
+115.7% vs SMA
RSI (14)
58.3
Neutral
Target vs 52W High
$30.47
-78.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +5.4% |
| AMGN | Hold | 43 | 49% | $190.87 | -52.7% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +179.1% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -9.5% |
| REGN | Buy | 38 | 71% | $76.80 | -90.0% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -42.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -46.0% |
| BIIB | Buy | 44 | 64% | $91.45 | -55.7% |